Companies
Sago
formerly Schlesinger Associates, runs one of the largest and longest-running US focus-group facility networks, marking 60 years in the industry in 2026 while adding AI-enabled qualitative-research tools.
- Country
- United States
US
Coverage
| EU | IN | US | |
|---|---|---|---|
| market-access-commercial | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Certification | Global ISO 9001 and ISO 20252 certifications | sago.com |
| Regulatory approval | FDA CFR Part-11 compliant, government vendor status | sago.com |
| Production site | Major markets including Atlanta, Chicago, Houston, Los Angeles, New Jersey, New York City, Philadelphia, Phoenix, St. Louis, Boston, Dallas, Orlando, and San Francisco | sago.com · qualtranscribe.com |
| Headcount | Approximately 1,100 to 1,200 employees as of 2026 | getlatka.com |
| Revenue | Estimated annual revenue between $100 million and $250 million | getlatka.com |
Independent sources: getlatka.com · qualtranscribe.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bio-product focus groups & A/B testing | market-access-commercial | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.